Novo Nordisk (NOVOB DC) announces that Etavopivat met its primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

Newsquawk StaffPublished On the live feed at 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Tesla (TSLA) owners are revolting over self-driving promises, WSJ reports

Iran is reviewing the US proposal delivered via Pakistan, ISNA reports

Novo Nordisk (NOVOB DC) announces that Etavopivat met its primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

BoJ is reportedly likely to keep rates on hold at April's meeting, Reuters reports citing sources; decision due to prolonged impact of Middle East war

US Administration officials told Punchbowl, Congress needs to pass the Senate’s DHS funding bill by the end of April; "This coming pay period, which ends Friday, is the last that the administration feels it can handle with its executive authority"

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

Related headlines

The whole workspace, free to try.

Try it free